SCHEMBL9059754

SCHEMBL9059754

Cc1cccc(NC(=N)N(C)C)c1-c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 3/20 0.49
MAPT P10636 1/20 0.41
HPGD P15428 3/20 0.40
ALDH1A1 P00352 5/20 0.39
KDM4E B2RXH2 1/20 0.39
FABP3 P05413 2/20 0.39
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36
GRIN2B Q13224 1/20 0.36
GRIN2C Q14957 1/20 0.36
GRIN3A Q8TCU5 1/20 0.36
SIGMAR1 Q99720 1/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
POLB P06746 2/20 0.36
HTT P42858 2/20 0.34
GLA P06280 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9537596 0.89 FABP4 (0.41) FABP4MAPTHPGDALDH1A1KDM4E
SCHEMBL9311252 0.77 FABP4 (0.49) FABP4MAPTHPGDALDH1A1KDM4E
SCHEMBL366745 0.77 FABP4 (0.62) FABP4MAPTHPGDALDH1A1KDM4E
SCHEMBL9059577 0.76 ALDH1A1 (0.45) FABP4ALDH1A1LMNA
SCHEMBL9059999 0.75 SMN1; SMN2 (0.39) MAPTALDH1A1KDM4ENPC1RAB9A
SCHEMBL2760761 0.71 FABP4 (0.55) FABP4MAPTHPGDALDH1A1KDM4E
SCHEMBL9059653 0.70 ALDH1A1 (0.49) FABP4MAPTALDH1A1KDM4ENPC1
SCHEMBL11280893 0.69 POLB (0.47) MAPTHPGDALDH1A1GRIN2DGRIN3B
SCHEMBL10797484 0.69 FABP4 (0.39) FABP4MAPTHPGDALDH1A1KDM4E
SCHEMBL9062891 0.69 POLB (0.47) FABP4POLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996017612-A1 USE OF SUBSTITUTED PHENYLAMIDINE AND PHENYLGUANIDINE COMPOUNDS FOR THE TREATMENT OF CEREBRAL AND CARDIAC ISCHAEMIA, CONVULSION AND SICKLE CELL ANAEMIA KNOLL AKTIENGESELLSCHAFT (DE) 1996-06-13 WO disclosed
EP-0536151-B1 ORTHOSUBSTITUTED BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM BOOTS CO PLC (GB) 1994-09-14 EP disclosed
US-5302720-A Biphenyl-substituted guanidine derivatives useful as hypoglycaemic agents THE BOOTS COMPANY (GB) 1994-04-12 US disclosed
EP-0536151-A1 ORTHOSUBSTITUTED BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM. BOOTS CO PLC (GB) 1993-04-14 EP disclosed
WO-1992000273-A1 ORTHOSUBSTITUTED BIPHENYL AMIDINE AND BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM THE BOOTS COMPANY PLC (GB) 1992-01-09 WO disclosed